A large pharmaceutical company faced a serious potential problem with FCPA compliance and partner due diligence processes. Through creation of a rigorous best practice FCPA program, the company was able to significantly mitigate their exposure through execution of an enhanced compliance plan.
For more information about Aravo, visit www.aravo.com.
Download Whitepaper
See All PharmaVOICE whitepapersFor more information about Aravo, visit www.aravo.com.
Download Whitepaper
Download Companion Podcast - Automating Pharma FCPA Due Diligence
Download Podcast Transcript (PDF)
